论文部分内容阅读
慢性丙型肝炎(CHC)因其没有有效的治疗方法而往往成为一种进行性肝脏疾病。本文研究的目的旨在评价长期大剂量(约15MU)应用重组α干扰素2C(rIFN-α2C)对CHC的疗效和重组Υ干扰素(rIFN-Υ)对CHC的潜在效果。作者把50例患者随机分为3组。第1组(10例)按7.5MU/m~2体表面
Chronic hepatitis C (CHC) is often a progressive liver disease because of its lack of effective treatment. The purpose of this study was to evaluate the long-term high-dose (about 15 MU) application of recombinant interferon-alpha 2C (rIFN-α2C) on CHC and the potential effect of recombinant IFN-γ on CHC. The authors randomized 50 patients to 3 groups. Group 1 (10 cases) by 7.5MU / m ~ 2 body surface